Skip to main content
. 2010 Jul-Sep;5(3):153–160. doi: 10.4103/1817-1737.65047

Figure 2.

Figure 2

Odds ratio of objective response rate of GBT vs. control interventions according to EGFR mutation status (random effects model). G, Gefitinib